{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:12:38Z","timestamp":1788567158962,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["BP2018017"],"award-info":[{"award-number":["BP2018017"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22494692"],"award-info":[{"award-number":["22494692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022YFC2804100"],"award-info":[{"award-number":["2022YFC2804100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92253303"],"award-info":[{"award-number":["92253303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82021003"],"award-info":[{"award-number":["82021003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22025702"],"award-info":[{"award-number":["22025702"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010260","name":"Xiamen Southern Oceanographic Center","doi-asserted-by":"publisher","award":["23YYZP020QCB26"],"award-info":[{"award-number":["23YYZP020QCB26"]}],"id":[{"id":"10.13039\/501100010260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20720230070"],"award-info":[{"award-number":["20720230070"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102420","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:56:33Z","timestamp":1761130593000},"page":"102420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the \u03b2-TrCP\/YAP\/ECM axis"],"prefix":"10.1016","volume":"6","author":[{"given":"Nan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-5864","authenticated-orcid":false,"given":"Xianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102420_bib1","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102420_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102420_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards targeting the breast cancer immune microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib5","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-18-3524","article-title":"Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer","volume":"25","author":"Xiao","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102420_bib6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI96313","article-title":"Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers","volume":"129","author":"Gruosso","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102420_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102420_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102420_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13058-019-1236-7","article-title":"NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis","volume":"21","author":"Wan","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102420_bib10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3389\/fonc.2020.01680","article-title":"NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics","volume":"10","author":"Jeon","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2025.102420_bib11","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1073\/pnas.1104303108","article-title":"Leukocyte composition of human breast cancer","volume":"109","author":"Ruffell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102420_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12885-019-5320-2","article-title":"Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer","volume":"19","author":"Konig","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib13","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58688","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"Nicolas-Boluda","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2025.102420_bib14","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102420_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.molmed.2021.07.009","article-title":"Extracellular matrix-based cancer targeting","volume":"27","author":"Karamanos","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102420_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2025.102420_bib17","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102420_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.it.2024.07.009","article-title":"The extracellular matrix in solid tumor immunotherapy","volume":"45","author":"Cho","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2025.102420_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib20","first-page":"1611","article-title":"The oncogenic roles and clinical implications of YAP\/TAZ in breast cancer","volume":"128","author":"Luo","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.1843810","article-title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF\u03b2-TRCP","volume":"24","author":"Zhao","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102420_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.18632\/oncotarget.1675","article-title":"SCF(\u03b2-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN\/Akt signaling pathway","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102420_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42997-z","article-title":"Discovery of Nedd4 auto-ubiquitination inhibitors","volume":"13","author":"Yong","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102420_bib24","doi-asserted-by":"crossref","first-page":"12442","DOI":"10.1021\/jacs.5b06839","article-title":"A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism","volume":"137","author":"Kathman","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.xcrm.2025.102420_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcp.2016.12.007","article-title":"Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells","volume":"127","author":"Quirit","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102420_bib26","doi-asserted-by":"crossref","first-page":"16736","DOI":"10.1073\/pnas.1412152111","article-title":"Peptide and small molecule inhibitors of HECT-type ubiquitin ligases","volume":"111","author":"Mund","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102420_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0463.2008.00999.x","article-title":"Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas","volume":"116","author":"Kim","year":"2008","journal-title":"Apmis"},{"key":"10.1016\/j.xcrm.2025.102420_bib28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1080\/15476286.2021.1885232","article-title":"NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation","volume":"18","author":"Yue","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.xcrm.2025.102420_bib29","article-title":"Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis","volume":"13","author":"Aiqin","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102420_bib30","article-title":"NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102420_bib31","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3892\/or.2017.5572","article-title":"Regulation of glioma migration and invasion via modification of Rap2a activity by the ubiquitin ligase Nedd4-1","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.xcrm.2025.102420_bib32","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3892\/ol.2017.6532","article-title":"NEDD4 promotes cell growth and migration via PTEN\/PI3K\/AKT signaling in hepatocellular carcinoma","volume":"14","author":"Huang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2025.102420_bib33","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.2353\/ajpath.2010.091075","article-title":"Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas","volume":"177","author":"Amodio","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2025.102420_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0366-6999.221262","article-title":"Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma","volume":"131","author":"Song","year":"2018","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.xcrm.2025.102420_bib35","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3892\/ijo.2013.2064","article-title":"Oncogenic function of p34SEI-1 via NEDD4-1-mediated PTEN ubiquitination\/degradation and activation of the PI3K\/AKT pathway","volume":"43","author":"Jung","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.xcrm.2025.102420_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni1047","article-title":"Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins","volume":"5","author":"Heissmeyer","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102420_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tranon.2018.01.011","article-title":"A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer","volume":"11","author":"Liu","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.xcrm.2025.102420_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102420_bib39","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102420_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-024-45160-y","article-title":"The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102420_bib41","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102420_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.annonc.2020.02.003","article-title":"Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer","volume":"31","author":"Adams","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102420_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/0008-5472.CAN-21-2362","article-title":"FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-Mediated Bladder Cancer Immune Surveillance","volume":"82","author":"Jing","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102420_bib44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCRESAHA.124.324872","article-title":"NEDD4-Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction","volume":"136","author":"Tang","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2025.102420_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(06)06032-0","article-title":"Degradation of RhoA by Smurf1 ubiquitin ligase","volume":"406","author":"Wang","year":"2006","journal-title":"Methods Enzymol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:13:30Z","timestamp":1788563610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004938"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102420","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the \u03b2-TrCP\/YAP\/ECM axis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102420"}}